| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials
|
Tinahones, F.J.
|
|
|
46 |
4 |
p. 280-287
|
artikel
|
| 2 |
Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes
|
Mantovani, A.
|
|
|
46 |
4 |
p. 326-330
|
artikel
|
| 3 |
Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients
|
Harada, M.
|
|
|
46 |
4 |
p. 331-334
|
artikel
|
| 4 |
Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)
|
Weir, N.L.
|
|
|
46 |
4 |
p. 319-325
|
artikel
|
| 5 |
Diabetes is associated with a higher risk of mortality among women in a middle-income country: Results form the Mexican Teacher's cohort study
|
Lozano-Esparza, S.
|
|
|
46 |
4 |
p. 304-310
|
artikel
|
| 6 |
Editorial board
|
|
|
|
46 |
4 |
p. i
|
artikel
|
| 7 |
Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints
|
Patoulias, D.
|
|
|
46 |
4 |
p. 272-279
|
artikel
|
| 8 |
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD
|
Sun, D.-Q.
|
|
|
46 |
4 |
p. 288-295
|
artikel
|
| 9 |
Metformin misuse in chronic kidney disease
|
Coliche, V.
|
|
|
46 |
4 |
p. 337-339
|
artikel
|
| 10 |
Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?
|
Caussy, Cyrielle
|
|
|
46 |
4 |
p. 259-260
|
artikel
|
| 11 |
Number Needed-to-Treat (NNT): Is it a necessary marker of therapeutic efficiency?
|
Monnier, L.
|
|
|
46 |
4 |
p. 261-264
|
artikel
|
| 12 |
Patients with diabetes are at higher risk for severe illness from COVID-19
|
Targher, G.
|
|
|
46 |
4 |
p. 335-337
|
artikel
|
| 13 |
Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets
|
Lan, N.S.R.
|
|
|
46 |
4 |
p. 339-341
|
artikel
|
| 14 |
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria
|
Cosson, E.
|
|
|
46 |
4 |
p. 311-318
|
artikel
|
| 15 |
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
|
Scheen, A.J.
|
|
|
46 |
4 |
p. 265-271
|
artikel
|
| 16 |
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
|
Mantovani, A.
|
|
|
46 |
4 |
p. 296-303
|
artikel
|
| 17 |
Severely uncontrolled diabetes: a new aetiology of acquired bisalbuminaemia
|
Lugat, Alexandre
|
|
|
46 |
4 |
p. 341-342
|
artikel
|
Tijdschrift beschrijving